Solasta Ventures focuses on investing in life sciences companies, particularly those developing therapeutics and technology that can transform patient care in the U.S. and globally. Their strategy involves identifying strong management teams and leveraging their South Korean network to foster potential US-Korea synergies and collaborations with global pharmaceutical companies.
Portfolio
2
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Axonis Therapeutics | Series A | $115M | Oct 2024 |
| HotSpot Therapeutics, Inc. | Series B | $65M | May 2020 |
Top Co-Investors
Sofinnova Partners2 shared
MRL Ventures Fund2 shared
Cormorant Asset Management1 shared
venBio1 shared
Perceptive Advisors1 shared
SC Ventures1 shared
Alexandria Venture Investments1 shared
Tekla Capital Management1 shared
Atlas Venture1 shared
Last updated: 3 March 2026